Breaking News Instant updates and real-time market news.

CRTO

Criteo

$46.14

0.13 (0.28%)

, AAPL

Apple

$156.17

-0.08 (-0.05%)

05:15
10/24/17
10/24
05:15
10/24/17
05:15

Criteo downgraded to Sector Weight from Overweight at KeyBanc

KeyBanc analyst Andy Hargreaves downgraded Criteo (CTRO) to Sector Weight saying the intelligent tracking prevention in Apple's (AAPL) new operating system appears likely to have a larger impact on the company's revenue than he previously expected. Criteo's workaround, while effective at tracking retail behavior, appears to be less than 50% effective at matching users on the publisher side, which is much lower than anticipated, Hargreaves tells investors in a research note. He lowered his fair value estimate for the shares to $49 from $62. The France-based company specializing in digital performance marketing closed yesterday up 13c to $46.14.

CRTO

Criteo

$46.14

0.13 (0.28%)

AAPL

Apple

$156.17

-0.08 (-0.05%)

  • 01

    Nov

  • 02

    Nov

CRTO Criteo
$46.14

0.13 (0.28%)

09/15/17
KEYB
09/15/17
NO CHANGE
Target $62
KEYB
Overweight
Criteo has workaround to Apple cookie disabler, says KeyBanc
KeyBanc analyst Andy Hargreaves recommends buying Criteo (CRTO) after the company at an event yesterday detailed its Commerce Marketing Platform, which aggregates online and offline data across partners to create a "Shopper Graph." The product has the potential to create new product areas, deepen partnerships and expand Criteo's "moat," Hargreaves tells investors in a research note. The stock has been weak on Apple's (AAPL) upcoming Intelligent Tracking Prevention rollout, which attempts to disable third-party tracking cookies after 24 hours, Hargreaves points out. He sees the issue as transitory, however, noting Criteo has a workaround that he believes will prove effective with direct publisher relationships. The analyst views Criteo's risk/reward as attractive and keeps an Overweight rating on the name with a $62 price target.
10/02/17
JMPS
10/02/17
INITIATION
Target $60
JMPS
Outperform
Criteo initiated with an Outperform at JMP Securities
JMP Securities analyst Andrew Boone started Criteo with an Outperform rating, as he predicts it will benefit from increased programmatic adoption expected over the next three to five years. The analyst, who thinks the company's data collectives are driving superior performance and that the Criteo Engine can continue to improve, set a $60 price target on the shares.
10/02/17
10/02/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Micron (MU) initiated with a Market Perform at BMO Capital. 2. Virtu Financial (VIRT) initiated with an In Line at Evercore ISI. 3. Viper Energy (VNOM) initiated with a Neutral at UBS. 4. Trade Desk (TTD) and Criteo (CRTO) were initiated with an Outperform at JMP Securities. 5. Myomo (MYO) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/12/17
MACQ
10/12/17
INITIATION
Target $51
MACQ
Neutral
Criteo initiated with a Neutral at Macquarie
Macquarie analyst Tim Nollen initiated Criteo with a Neutral and $51 price target. The analyst said the retail sector could face more pressure going forward, putting general marketing budgets at risk.
AAPL Apple
$156.17

-0.08 (-0.05%)

10/19/17
DRXL
10/19/17
NO CHANGE
Target $208
DRXL
Buy
Drexel Hamilton 'aggressive buyers' of Apple on order cut report weakness
Drexel Hamilton analyst Brian White said he would be an "aggressive buyer" of Apple shares amid the weakness that he attributes to media reports around order cuts for the iPhone 8/8 Plus. He believes the staggered launch of the iPhone 8/8 Plus and iPhone X is causing more confusing data points relative to past cycles and notes that Apple has cut forecasts before "even during some of the best iPhone cycles." The analyst, who notes that consumers are waiting on the iPhone X, keeps a Buy rating and $208 price target on Apple shares, which are down 2.4% to $155.92 in early trading.
10/23/17
UBSW
10/23/17
NO CHANGE
Target $180
UBSW
Buy
Apple supply/demand speculation should mostly be ignored, says UBS
UBS analyst Steven Milunovich said there has been significant speculation about supply/demand surrounding Apple's newest iPhones and he believes it should mostly be ignored. The analyst said that in the U.S. the next 90-day buying level intentions are at the highest level since the iPhone 6, 43% of buyers expect to buy the iPhone X, the iPhone retention rate is at its highest ever, and the iPhone 8 Plus is outselling the iPhone 8. He believes any weakness in the iPhone 8 is most likely due to the strong demand of the iPhone X. Milunovich reiterated his Buy rating and $180 price target on Apple shares.
10/23/17
RBCM
10/23/17
NO CHANGE
Target $180
RBCM
Outperform
Apple bull case now more compelling, says RBC Capital
RBC Capital analyst Amit Daryanani maintained his Outperform rating and $180 price target on Apple. Daryanani says that while reports of soft iPhone 8 sales have recently weighed on the company's supply chain as well as the Apple stock, the bull case is "more powerful" today than it was 90 days ago, as investment focus shifts to a "super-long" cycle where revenue, EPS, and units sold growth by double digits in FY18 and FY19. Despite some initial hiccups, the analyst writes in his research note, the iPhone X will also generate solid demand and gross margin expansion tailwinds.
10/23/17
BERN
10/23/17
NO CHANGE
Target $175
BERN
Outperform
Apple iPhone near-term upgrade intention appears healthy, says Bernstein
Bernstein analyst A.M. Sacconaghi says his proprietary survey of 1112 Apple iPhone owners across three geographies, namely the U.S., U.K., and China, suggests iPhone's near-term upgrade intention is healthy, supporting his thesis of a forthcoming iPhone super-cycle. Additionally, the analyst says consumer loyalty to iPhone remains "remarkably strong," demand for the iPhone X will be "substantial, but not exceptional," and rumored delays in the iPhone X do not appear likely to depress sales materially, since consumers appear to be relatively patient with Apple. He reiterates an Outperform rating and $175 price target on the shares.

TODAY'S FREE FLY STORIES

GSK

GlaxoSmithKline

$34.91

-0.21 (-0.60%)

, PFE

Pfizer

$35.61

0.2648 (0.75%)

14:05
11/21/17
11/21
14:05
11/21/17
14:05
Hot Stocks
FDA approves ViiV Healthcare's two drug HIV treatment Juluca »

The FDA today said it…

GSK

GlaxoSmithKline

$34.91

-0.21 (-0.60%)

PFE

Pfizer

$35.61

0.2648 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 07

    Dec

  • 14

    Dec

OCLR

Oclaro

$6.49

-0.09 (-1.37%)

14:05
11/21/17
11/21
14:05
11/21/17
14:05
Options
Oclaro call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 12

    Dec

NUE

Nucor

$56.02

0.46 (0.83%)

14:04
11/21/17
11/21
14:04
11/21/17
14:04
Hot Stocks
Nucor announces plans to build rebar micro mill »

Nucor announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

14:01
11/21/17
11/21
14:01
11/21/17
14:01
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

13:59
11/21/17
11/21
13:59
11/21/17
13:59
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SSNLF

Samsung

, WHR

Whirlpool

$166.91

1.71 (1.04%)

13:58
11/21/17
11/21
13:58
11/21/17
13:58
Periodicals
ITC calls for tariff-rate quota on imported Samsung, LG washers, Reuters says »

The U.S. International…

SSNLF

Samsung

WHR

Whirlpool

$166.91

1.71 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RF

Regions Financial

$15.70

-0.16 (-1.01%)

13:55
11/21/17
11/21
13:55
11/21/17
13:55
Options
Regions Financial put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLMT

Calumet Specialty Products

$8.30

0.1 (1.22%)

13:53
11/21/17
11/21
13:53
11/21/17
13:53
Hot Stocks
Calumet Specialty Products announces divestiture of Anchor Drilling Fluids »

Calumet Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITUS

ITUS

$3.16

0.25 (8.59%)

13:53
11/21/17
11/21
13:53
11/21/17
13:53
Conference/Events
ITUS to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$15.03

-0.0315 (-0.21%)

13:49
11/21/17
11/21
13:49
11/21/17
13:49
Downgrade
Enable Midstream rating change  »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLY

Stanley Furniture

$0.93

0.0349 (3.92%)

13:47
11/21/17
11/21
13:47
11/21/17
13:47
Hot Stocks
Stanley Furniture to sell substantially all its assets »

As previously reported,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
11/21/17
11/21
13:40
11/21/17
13:40
General news
NY Fed's overnight reverse repo totaled $42.9 B (19 counterparties) »

NY Fed's overnight…

EYE

National Vision

$30.19

0.21 (0.70%)

13:33
11/21/17
11/21
13:33
11/21/17
13:33
Initiation
National Vision initiated  »

National Vision initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

13:32
11/21/17
11/21
13:32
11/21/17
13:32
Downgrade
Cytokinetics rating change  »

Cytokinetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

LOW

Lowe's

$81.59

0.13 (0.16%)

13:27
11/21/17
11/21
13:27
11/21/17
13:27
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

WHR

Whirlpool

$165.67

0.47 (0.28%)

13:25
11/21/17
11/21
13:25
11/21/17
13:25
Periodicals
ITC suggests tariffs on washing machine imports above 1.2M units, Bloomberg says »

Two of four ITC officials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWI

Armstrong World

$53.70

-0.15 (-0.28%)

13:25
11/21/17
11/21
13:25
11/21/17
13:25
Conference/Events
Armstrong World to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BMO

Bank of Montreal

$77.39

0.06 (0.08%)

13:21
11/21/17
11/21
13:21
11/21/17
13:21
Hot Stocks
BMO Financial Group enters partnership with CDL-Montreal »

BMO Financial Group and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
11/21/17
11/21
13:20
11/21/17
13:20
General news
Fed Governor Powell's hearings for the position as Fed Chair »

Fed Governor…

PG

Procter & Gamble

$88.93

0.66 (0.75%)

13:20
11/21/17
11/21
13:20
11/21/17
13:20
Options
Buyer lays out 500K for three month upside in Procter and Gamble »

Buyer lays out 500K for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
11/21/17
11/21
13:17
11/21/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
11/21/17
11/21
13:16
11/21/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$49.71

-0.21 (-0.42%)

13:05
11/21/17
11/21
13:05
11/21/17
13:05
Options
CSX call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

13:05
11/21/17
11/21
13:05
11/21/17
13:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

SIG

Signet Jewelers

$54.67

-21.17 (-27.91%)

13:01
11/21/17
11/21
13:01
11/21/17
13:01
Downgrade
Signet Jewelers rating change  »

Wells Fargo downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.